| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 42,862,184 | 59,126,072 | 57,397,712 | | Cost of Revenue | 9,370,809 | 13,989,089 | 10,614,404 | | | Gross Profit | 33,491,375 | 45,136,983 | 46,783,308 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 7,626,089 | 24,884,361 | 27,617,433 | | Non Recurring | 4,505,865 | 2,274,925 | 3,046,401 | | Others | 15,298,511 | 2,456,679 | 1,212,683 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,060,909 | 15,521,018 | 14,906,792 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,060,909 | 15,521,018 | 14,906,792 | | Interest Expense | 4,892,454 | 7,531,818 | 6,584,535 | | Income Before Tax | 1,168,455 | 7,989,200 | 8,322,257 | | Income Tax Expense | (55,020) | 1,356,167 | 2,627,153 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,223,476 | 6,633,033 | 5,695,104 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,223,476 | 6,633,033 | 5,695,104 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,223,476 | $6,633,033 | $5,695,104 |
|
0.18% Nasdaq 0.00%
Income Statement
